TVGN - Tevogen Bio Holdings Inc.
1.04
-0.010 -0.962%
Share volume: 400,377
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.05
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-28-2024 | 08-14-2024 | 11-19-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 29.517 M | 8.599 M | 6.086 M | |
| Selling general and admin | 8.705 M | 4.475 M | 2.825 M | |
| Research and development | 20.812 M | 4.124 M | 3.261 M | |
| Total expenses | 37.016 M | 8.599 M | 6.086 M | |
| -76.77% | -29.23% | |||
| Operating income | -29.517 M | -8.599 M | -6.086 M | |
| Ebit | 18.920 M | -9.663 M | -5.872 M | |
| Pretax income | 11.265 M | -9.663 M | -5.884 M | |
| -185.78% | -39.11% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | 11.265 M | -9.663 M | -5.884 M | |
| -185.78% | 39.11% |
